Clinical Trial Update: Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating minimising calcineurin inhibitor exposure in renal transplant recipients with stable allograft function to maintain gra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Chronic Allograft Nephropathy | Phase 4 | Status: UNKNOWN